in line, outlook remains challenging (trading -0.60%) Fresenius and Fresenius Medical Q1's in line with pre announcement last week (trading +1.7%) PagesJaunes Q1 sales inline with estimates, net misses, confirms outlook (trading +0.30%) MAN SE Q1 in line with prelims, reiterates forecast for lower sales in 2